SPRO
Spero Therapeutics Inc

2,757
Mkt Cap
$130.71M
Volume
465,242.00
52W High
$3.22
52W Low
$0.5052
PE Ratio
-2.92
SPRO Fundamentals
Price
$2.32
Prev Close
$2.29
Open
$2.35
50D MA
$2.35
Beta
0.85
Avg. Volume
494,873.16
EPS (Annual)
-$1.27
P/B
4.93
Rev/Employee
$856,125.00
Loading...
Loading...
News
all
press releases
Spero Therapeutics (NASDAQ:SPRO) Upgraded to "Buy" at Wall Street Zen
Wall Street Zen raised Spero Therapeutics from a "hold" rating to a "buy" rating in a research report on Sunday...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Stock Rating Lowered by Wall Street Zen
Wall Street Zen downgraded Spero Therapeutics from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat·15d ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Upgraded to "Buy" at Wall Street Zen
Wall Street Zen raised Spero Therapeutics from a "hold" rating to a "buy" rating in a research note on Friday...
MarketBeat·22d ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Shares Pass Above 200 Day Moving Average on Insider Selling
Spero Therapeutics (NASDAQ:SPRO) Shares Cross Above Two Hundred Day Moving Average After Insider Selling...
MarketBeat·1mo ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Issues Earnings Results, Beats Estimates By $0.12 EPS
Spero Therapeutics (NASDAQ:SPRO - Get Free Report) announced its earnings results on Thursday. The company reported ($0.13) EPS for the quarter, topping analysts' consensus estimates of ($0.25) by...
MarketBeat·1mo ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Insider Esther Rajavelu Sells 40,270 Shares
Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) insider Esther Rajavelu sold 40,270 shares of the stock in a transaction on Friday, November 7th. The shares were sold at an average price of...
MarketBeat·1mo ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Insider Sells $95,439.90 in Stock
Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) insider Esther Rajavelu sold 40,270 shares of the business's stock in a transaction that occurred on Friday, November 7th. The stock was sold...
MarketBeat·1mo ago
News Placeholder
Best Momentum Stock to Buy for October 10th
SPRO made it to the Zacks Rank #1 (Strong Buy) momentum stock list on October 10, 2025.
Zacks·2mo ago
News Placeholder
Bayer Reports Positive Data on Cell Therapy for Parkinson's Disease
BAYRY's subsidiary BlueRock reports 36-month data showing its Parkinson's therapy bemdaneprocel remains safe and effective in easing motor symptoms.
Zacks·2mo ago
News Placeholder
Down 17.7% in 4 Weeks, Here's Why Spero Therapeutics (SPRO) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Spero Therapeutics (SPRO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Zacks·4mo ago
<
1
2
...
>

Latest SPRO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.